Sectoral Asset Management’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

Sectoral Asset Management’s Portfolio RXDX Stock Details RXDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-108,090	Closed	-$11.6M	–	132
2023 Q1	$11.6M	Sell	108,090 -4,120	-4%	-$474K	2.23%	6
2022 Q4	$12.3M	Buy	112,210 +9,000	+9%	+$584K	2.39%	6
2022 Q3	$6.09M	Sell	103,210 -69,295	-40%	-$3.17M	1.2%	29
2022 Q2	$4.87M	Buy	+172,505	New	+$5M	0.98%	43

Other funds holding RXDX

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

FCA

FinTrust Capital Advisors Greenville, South Carolina $591M AUM 26.89% 1-Year Est. Return

Sectoral Asset Management's RXDX Position: Q2 2023 in Review

Sectoral Asset Management sold out of Prometheus Biosciences, Inc. Common Stock (RXDX) in Q2 2023, closing a stake of 108,090 shares — an estimated $11.6M sold.

Sectoral Asset Management first reported a position in RXDX in Q2 2022 and held it in 4 quarters. The position peaked at $12.3M in Q4 2022. 2 funds tracked by Wall St. Rank hold RXDX as of Q2 2023.

Sectoral Asset Management reported no remaining Prometheus Biosciences, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Sectoral Asset Management sold 108,090 Prometheus Biosciences, Inc. Common Stock shares in Q2 2023, an estimated $11.6M.
Sectoral Asset Management first reported a position in Prometheus Biosciences, Inc. Common Stock in Q2 2022 and held it in 4 quarters.
Sectoral Asset Management's Prometheus Biosciences, Inc. Common Stock position peaked at $12.3M in Q4 2022.
2 funds tracked by Wall St. Rank held Prometheus Biosciences, Inc. Common Stock as of Q2 2023.

Based on Sectoral Asset Management's 13F filing for Q2 2023, filed 11 Aug 2023.